Efficacy and safety of azilsartan medoxomil/chlortalidone fixed‐dose combination in hypertensive patients uncontrolled on azilsartan medoxomil alone: A randomized trial

Patients with grade 2‐3 essential hypertension and postplacebo mean clinic systolic blood pressure (SBP) 160‐190 mm Hg and 24‐hour SBP 140‐175 mm Hg by ambulatory blood pressure monitoring (ABPM) received 40 mg azilsartan medoxomil (AZL‐M) monotherapy for 4 weeks. “Nonresponders” were then randomize...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Clin Hypertens (Greenwich)
Päätekijät: Collier, David J., Juhasz, Attila, Agabiti‐Rosei, Enrico, Lloyd, Eric, Hisada, Michie, Zhao, Lin, Kupfer, Stuart, Caulfield, Mark J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley and Sons Inc. 2018
Aiheet:
Therapeutics
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8030929/
https://ncbi.nlm.nih.gov/pubmed/30302936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13376
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia